Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2022-07-01
2024-07-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mediterranean Diet Education in Shift Nurses: Effects on Sleep, Activity, and Health Parameters
NCT07123610
The Effect of Nutrition Education on Premenstrual Syndrome
NCT05144568
The Effect of Motivational Interviewing on Knowledge, Self-Efficacy, and Treatment Adherence in Patients With Primary Hypertension Living in Semi-Rural Areas
NCT07307924
The Effect of Change Stage-Based Physical Activity Counseling on Physically Inactive Individuals With Hypertension
NCT07068100
The Effect of Modular Education on Individuals Diagnosed With Hypertension
NCT06816732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diet education
Mediterranean diet education
Mediterranean diet education
The General Information Form, Physical Activity Questionnaire, Perceived Stress Scale, SF-36 Quality of Life Scale, and Mediterranean Diet Adherence Scale will be administered to hypertensive patients at each interview (at 0, 1, and 3 months). The intervention group will be trained on the Mediterranean Diet at the first meeting.
Kontrol
Control
The General Information Form, Physical Activity Questionnaire, Perceived Stress Scale, SF-36 Quality of Life Scale, and Mediterranean Diet Adherence Scale will be administered to hypertensive patients at each interview (at 0, 1, and 3 months).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mediterranean diet education
The General Information Form, Physical Activity Questionnaire, Perceived Stress Scale, SF-36 Quality of Life Scale, and Mediterranean Diet Adherence Scale will be administered to hypertensive patients at each interview (at 0, 1, and 3 months). The intervention group will be trained on the Mediterranean Diet at the first meeting.
Control
The General Information Form, Physical Activity Questionnaire, Perceived Stress Scale, SF-36 Quality of Life Scale, and Mediterranean Diet Adherence Scale will be administered to hypertensive patients at each interview (at 0, 1, and 3 months).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being willing and able to participate in the study
* Being diagnosed with primary hypertension at least 6 months ago
* Being in the inactive group according to the International Physical Activity Questionnaire
* Having a score of 35 or below on the Perceived Stress Scale
* Being literate.
Exclusion Criteria
* If the patient is a woman, they are pregnant
* Having been diagnosed with an eating disorder
* Having been diagnosed with a psychiatric diagnosis and/or receiving psychological support
* Being on antidepressants and/or steroids
* Being on any diet/receiving dietitian support
* Having been diagnosed with heart failure, chronic kidney disease (CHF), cirrhosis, gastrointestinal system (GIS), or endocrine disease
* Having been diagnosed with depression
* Being on enteral or parenteral nutrition
* Being a smoker
* Having a mental or communication disability that would prevent the patient from answering questions
* Having a body mass index of 30 or higher.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uludag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hicran Yıldız
Prof.Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hicran Yıldız, Prof.Dr.
Role: PRINCIPAL_INVESTIGATOR
Bursa Uludag Unversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dumlupınar Family Health Center
Bursa, Nilüfer, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UludağU1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.